Verition Fund Management LLC Harvard Bioscience Inc Transaction History
Verition Fund Management LLC
- $19.9 Billion
- Q1 2025
A detailed history of Verition Fund Management LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 12,370 shares of HBIO stock, worth $5,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,370
Previous 32,160
61.54%
Holding current value
$5,937
Previous $67,000
89.55%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HBIO
# of Institutions
81Shares Held
22.5MCall Options Held
8.7KPut Options Held
2K-
Amh Equity LTD3.51MShares$1.68 Million2.13% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.36 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.19MShares$1.05 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$889,8670.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.53MShares$733,3890.05% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $20M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...